Kiniksa Pharmaceuticals International, plc KNSA Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Kiniksa Pharmaceuticals International, plc in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The official record: Kiniksa Pharmaceuticals International, plc’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kiniksa Pharmaceuticals International, plc's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kiniksa Pharmaceuticals International, plc's total current assets?
- Kiniksa Pharmaceuticals International, plc (KNSA) reported total current assets of $594.17M in Q1 2026.
- How has Kiniksa Pharmaceuticals International, plc's total current assets changed year-over-year?
- Kiniksa Pharmaceuticals International, plc's total current assets increased by 66.9% year-over-year, from $355.91M to $594.17M.
- What is the long-term trend for Kiniksa Pharmaceuticals International, plc's total current assets?
- Over 5 years (2020 to 2025), Kiniksa Pharmaceuticals International, plc's total current assets has grown at a 9.6% compound annual growth rate (CAGR), from $333.25M to $527.18M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.